Search

Your search keyword '"Bosch, F Xavier"' showing total 780 results
Start Over Author "Bosch, F Xavier"
780 results on '"Bosch, F Xavier"'

4. Comprehensive Control of Human Papillomavirus Infections and Related Diseases

Author

Bosch, F Xavier, Broker, Thomas R, Forman, David, Moscicki, Anna-Barbara, Gillison, Maura L, Doorbar, John, Stern, Peter L, Stanley, Margaret, Arbyn, Marc, Poljak, Mario, Cuzick, Jack, Castle, Philip E, Schiller, John T, Markowitz, Lauri E, Fisher, William A, Canfell, Karen, Denny, Lynette A, Franco, Eduardo L, Steben, Marc, Kane, Mark A, Schiffman, Mark, Meijer, Chris JLM, Sankaranarayanan, Rengaswamy, Castellsagué, Xavier, Kim, Jane J, Brotons, Maria, Alemany, Laia, Albero, Ginesa, Diaz, Mireia, de Sanjosé, Silvia, and on behalf of the authors of the ICO Monograph ‘Comprehensive Control of HPV Infections and Related Diseases’ Vaccine Volume 30, Supplement 5

Subjects
HIV/AIDS, Clinical Research, Vaccine Related, Prevention, Cancer, Infectious Diseases, Sexually Transmitted Infections, Immunization, HPV and/or Cervical Cancer Vaccines, Cervical Cancer, Prevention of disease and conditions, and promotion of well-being, 3.4 Vaccines, Infection, Good Health and Well Being, HPV, Cervical cancer, Anal cancer, Penile cancer, Vaginal cancer, authors of ICO Monograph Comprehensive Control of HPV Infections and Related Diseases Vaccine Volume 30, Supplement 5, 2012, HPV testing, HPV vaccination, Oropharyngeal cancer, Screening, Vulvar cancer, Biological Sciences, Agricultural and Veterinary Sciences, Medical and Health Sciences, Virology
Abstract

Infection with human papillomavirus (HPV) is recognized as one of the major causes of infection-related cancer worldwide, as well as the causal factor in other diseases. Strong evidence for a causal etiology with HPV has been stated by the International Agency for Research on Cancer for cancers of the cervix uteri, penis, vulva, vagina, anus and oropharynx (including base of the tongue and tonsils). Of the estimated 12.7 million new cancers occurring in 2008 worldwide, 4.8% were attributable to HPV infection, with substantially higher incidence and mortality rates seen in developing versus developed countries. In recent years, we have gained tremendous knowledge about HPVs and their interactions with host cells, tissues and the immune system; have validated and implemented strategies for safe and efficacious prophylactic vaccination against HPV infections; have developed increasingly sensitive and specific molecular diagnostic tools for HPV detection for use in cervical cancer screening; and have substantially increased global awareness of HPV and its many associated diseases in women, men, and children. While these achievements exemplify the success of biomedical research in generating important public health interventions, they also generate new and daunting challenges: costs of HPV prevention and medical care, the implementation of what is technically possible, socio-political resistance to prevention opportunities, and the very wide ranges of national economic capabilities and health care systems. Gains and challenges faced in the quest for comprehensive control of HPV infection and HPV-related cancers and other disease are summarized in this review. The information presented may be viewed in terms of a reframed paradigm of prevention of cervical cancer and other HPV-related diseases that will include strategic combinations of at least four major components: 1) routine introduction of HPV vaccines to women in all countries, 2) extension and simplification of existing screening programs using HPV-based technology, 3) extension of adapted screening programs to developing populations, and 4) consideration of the broader spectrum of cancers and other diseases preventable by HPV vaccination in women, as well as in men. Despite the huge advances already achieved, there must be ongoing efforts including international advocacy to achieve widespread-optimally universal-implementation of HPV prevention strategies in both developed and developing countries. This article summarizes information from the chapters presented in a special ICO Monograph 'Comprehensive Control of HPV Infections and Related Diseases' Vaccine Volume 30, Supplement 5, 2012. Additional details on each subtopic and full information regarding the supporting literature references may be found in the original chapters.

Published
2013

6. List of Contributors

Author

Alemany, Laia, primary, Arbyn, Marc, additional, Beeravolu, Harshita, additional, Bergeron, Christine, additional, Berkhof, Johannes, additional, Bhatla, Neerja, additional, Bosch, F. Xavier, additional, Broker, Thomas R., additional, Bruni, Laia, additional, Canarte, Veronica, additional, Canfell, Karen, additional, Corcoran, Brenda, additional, Cubie, Heather, additional, Cuschieri, Kate, additional, Cuzick, J., additional, Denny, Lynette, additional, Doorbar, John, additional, Dutta, Tapati, additional, Fakhry, Carole, additional, Faraji, Farhoud, additional, Forster, Alice, additional, Franceschi, Silva, additional, Franco, Eduardo L., additional, Garland, Suzanne M., additional, Geraets, Daan, additional, Giuliano, Anna R., additional, Grace, Miranda, additional, Guimera, Nuria, additional, Hanley, Sharon, additional, Heideman, D.A.M., additional, Jenkins, David, additional, Joura, Elmar, additional, Kremer, W.W., additional, Lacey, Charles J.N., additional, Leeman, Annemiek, additional, Lorincz, Attila, additional, Markowitz, Lauri E., additional, Meijer, Chris J.L.M., additional, Meyerson, Beth E., additional, Moscicki, Anna-Barbara, additional, Munger, Karl, additional, Muñoz, Nubia, additional, Paavonen, Jorma, additional, Palefsky, Joel M., additional, Pollock, Kevin G., additional, Quint, Wim, additional, Ronco, G., additional, Schiffman, Mark, additional, Sharma, Surendra, additional, Singer, Albert, additional, Stanley, Margaret, additional, Stoler, Mark H., additional, von Knebel Doeberitz, Magnus, additional, Wheeler, Cosette Marie, additional, Wu, Sharon C., additional, and Zimet, Gregory D., additional

Published
2020
Full Text
View/download PDF

12. Data from A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions

Author

Kjaer, Susanne K., primary, Sigurdsson, Kristján, primary, Iversen, Ole-Erik, primary, Hernandez-Avila, Mauricio, primary, Wheeler, Cosette M., primary, Perez, Gonzalo, primary, Brown, Darron R., primary, Koutsky, Laura A., primary, Tay, Eng Hseon, primary, García, Patricia, primary, Ault, Kevin A., primary, Garland, Suzanne M., primary, Leodolter, Sepp, primary, Olsson, Sven-Eric, primary, Tang, Grace W.K., primary, Ferris, Daron G., primary, Paavonen, Jorma, primary, Lehtinen, Matti, primary, Steben, Marc, primary, Bosch, F. Xavier, primary, Dillner, Joakim, primary, Joura, Elmar A., primary, Majewski, Slawomir, primary, Muñoz, Nubia, primary, Myers, Evan R., primary, Villa, Luisa L., primary, Taddeo, Frank J., primary, Roberts, Christine, primary, Tadesse, Amha, primary, Bryan, Janine, primary, Maansson, Roger, primary, Lu, Shuang, primary, Vuocolo, Scott, primary, Hesley, Teresa M., primary, Saah, Alfred, primary, Barr, Eliav, primary, and Haupt, Richard M., primary

Published
2023
Full Text
View/download PDF

13. Supplementary Tables 1-2 from A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions

Author

Kjaer, Susanne K., primary, Sigurdsson, Kristján, primary, Iversen, Ole-Erik, primary, Hernandez-Avila, Mauricio, primary, Wheeler, Cosette M., primary, Perez, Gonzalo, primary, Brown, Darron R., primary, Koutsky, Laura A., primary, Tay, Eng Hseon, primary, García, Patricia, primary, Ault, Kevin A., primary, Garland, Suzanne M., primary, Leodolter, Sepp, primary, Olsson, Sven-Eric, primary, Tang, Grace W.K., primary, Ferris, Daron G., primary, Paavonen, Jorma, primary, Lehtinen, Matti, primary, Steben, Marc, primary, Bosch, F. Xavier, primary, Dillner, Joakim, primary, Joura, Elmar A., primary, Majewski, Slawomir, primary, Muñoz, Nubia, primary, Myers, Evan R., primary, Villa, Luisa L., primary, Taddeo, Frank J., primary, Roberts, Christine, primary, Tadesse, Amha, primary, Bryan, Janine, primary, Maansson, Roger, primary, Lu, Shuang, primary, Vuocolo, Scott, primary, Hesley, Teresa M., primary, Saah, Alfred, primary, Barr, Eliav, primary, and Haupt, Richard M., primary

Published
2023
Full Text
View/download PDF

14. Supplementary Tables 1-2 from Attribution of 12 High-Risk Human Papillomavirus Genotypes to Infection and Cervical Disease

Author

Joura, Elmar A., primary, Ault, Kevin A., primary, Bosch, F. Xavier, primary, Brown, Darron, primary, Cuzick, Jack, primary, Ferris, Daron, primary, Garland, Suzanne M., primary, Giuliano, Anna R., primary, Hernandez-Avila, Mauricio, primary, Huh, Warner, primary, Iversen, Ole-Erik, primary, Kjaer, Susanne K., primary, Luna, Joaquin, primary, Miller, Dianne, primary, Monsonego, Joseph, primary, Munoz, Nubia, primary, Myers, Evan, primary, Paavonen, Jorma, primary, Pitisuttithum, Punnee, primary, Steben, Marc, primary, Wheeler, Cosette M., primary, Perez, Gonzalo, primary, Saah, Alfred, primary, Luxembourg, Alain, primary, Sings, Heather L., primary, and Velicer, Christine, primary

Published
2023
Full Text
View/download PDF

15. Supplementary Material from Attribution of 12 High-Risk Human Papillomavirus Genotypes to Infection and Cervical Disease

Author

Joura, Elmar A., primary, Ault, Kevin A., primary, Bosch, F. Xavier, primary, Brown, Darron, primary, Cuzick, Jack, primary, Ferris, Daron, primary, Garland, Suzanne M., primary, Giuliano, Anna R., primary, Hernandez-Avila, Mauricio, primary, Huh, Warner, primary, Iversen, Ole-Erik, primary, Kjaer, Susanne K., primary, Luna, Joaquin, primary, Miller, Dianne, primary, Monsonego, Joseph, primary, Munoz, Nubia, primary, Myers, Evan, primary, Paavonen, Jorma, primary, Pitisuttithum, Punnee, primary, Steben, Marc, primary, Wheeler, Cosette M., primary, Perez, Gonzalo, primary, Saah, Alfred, primary, Luxembourg, Alain, primary, Sings, Heather L., primary, and Velicer, Christine, primary

Published
2023
Full Text
View/download PDF

29. Human Papillomavirus Genotypes From Vaginal and Vulvar Intraepithelial Neoplasia in Females 15–26 Years of Age

Author

Garland, Suzanne M., Joura, Elmar A., Ault, Kevin A., Bosch, F. Xavier, Brown, Darron R., Castellsagué, Xavier, Ferenczy, Alex, Ferris, Daron G., Giuliano, Anna R., Hernandez-Avila, Mauricio, Huh, Warner K., Iversen, Ole-Erik, Kjaer, Susanne K., Kurman, Robert J., Luna, Joaquin, Monsonego, Joseph, Muñoz, Nubia, Paavonen, Jorma, Pitisuttihum, Punnee, Ronnett, Brigitte M., Steben, Marc, Stoler, Mark H., Wheeler, Cosette M., Wiley, Dorothy J., Perez, Gonzalo, Saah, Alfred J., Luxembourg, Alain, Li, Se, DiNubile, Mark J., Wagner, Monika, and Velicer, Christine

Published
2018
Full Text
View/download PDF

30. Risk of Newly Detected Infections and Cervical Abnormalities in Women Seropositive for Naturally Acquired Human Papillomavirus Type 16/18 Antibodies: Analysis of the Control Arm of PATRICIA

Author

Castellsagué, Xavier, Naud, Paulo, Chow, Song-Nan, Wheeler, Cosette M., Germar, Maria Julieta V., Lehtinen, Matti, Paavonen, Jorma, Jaisamrarn, Unnop, Garland, Suzanne M., Salmerón, Jorge, Apter, Dan, Kitchener, Henry, Teixeira, Julio C., Skinner, S. Rachel, Limson, Genara, Szarewski, Anne, Romanowski, Barbara, Aoki, Fred Y., Schwarz, Tino F., Poppe, Willy A. J., Bosch, F. Xavier, de Carvalho, Newton S., Peters, Klaus, Tjalma, Wiebren A. A., Safaeian, Mahboobeh, Raillard, Alice, Descamps, Dominique, Struyf, Frank, Dubin, Gary, Rosillon, Dominique, and Baril, Laurence

Published
2014

33. Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial

Author

Roset Bahmanyar, Edith, Paavonen, Jorma, Naud, Paulo, Salmerón, Jorge, Chow, Song-Nan, Apter, Dan, Kitchener, Henry, Castellsagué, Xavier, Teixeira, Julio C., Skinner, S. Rachel, Jaisamrarn, Unnop, Limson, Genara A., Garland, Suzanne M., Szarewski, Anne, Romanowski, Barbara, Aoki, Fred, Schwarz, Tino F., Poppe, Willy A.J., De Carvalho, Newton S., Harper, Diane M., Bosch, F. Xavier, Raillard, Alice, Descamps, Dominique, Struyf, Frank, Lehtinen, Matti, and Dubin, Gary

Published
2012
Full Text
View/download PDF

35. Human papillomavirus genotype distribution in cervical cancer cases in Spain. Implications for prevention

Author

Alemany, Laia, Pérez, Cristina, Tous, Sara, Llombart-Bosch, Antonio, Lloveras, Belen, Lerma, Enrique, Guarch, Rosa, Andújar, Miguel, Pelayo, Adela, Alejo, Maria, Ordi, Jaume, Klaustermeier, Joellen, Velasco, Julio, Guimerà, Nuria, Clavero, Omar, Castellsagué, Xavier, Quint, Wim, Muñoz, Nubia, Bosch, F. Xavier, and de Sanjosé, Silvia

Published
2012
Full Text
View/download PDF

36. Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

Author

Wheeler, Cosette M, Castellsagué, Xavier, Garland, Suzanne M, Szarewski, Anne, Paavonen, Jorma, Naud, Paulo, Salmerón, Jorge, Chow, Song-Nan, Apter, Dan, Kitchener, Henry, Teixeira, Júlio C, Skinner, S Rachel, Jaisamrarn, Unnop, Limson, Genara, Romanowski, Barbara, Aoki, Fred Y, Schwarz, Tino F, Poppe, Willy A J, Bosch, F Xavier, Harper, Diane M, Huh, Warner, Hardt, Karin, Zahaf, Toufik, Descamps, Dominique, Struyf, Frank, Dubin, Gary, and Lehtinen, Matti

Published
2012
Full Text
View/download PDF

37. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

Author

Lehtinen, Matti, Paavonen, Jorma, Wheeler, Cosette M, Jaisamrarn, Unnop, Garland, Suzanne M, Castellsagué, Xavier, Skinner, S Rachel, Apter, Dan, Naud, Paulo, Salmerón, Jorge, Chow, Song-Nan, Kitchener, Henry, Teixeira, Júlio C, Hedrick, James, Limson, Genara, Szarewski, Anne, Romanowski, Barbara, Aoki, Fred Y, Schwarz, Tino F, Poppe, Willy A J, De Carvalho, Newton S, Germar, Maria Julieta V, Peters, Klaus, Mindel, Adrian, De Sutter, Philippe, Bosch, F Xavier, David, Marie-Pierre, Descamps, Dominique, Struyf, Frank, and Dubin, Gary

Published
2012
Full Text
View/download PDF

39. The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Sexually Active Women Aged 16-26 Years

Author

Wheeler, Cosette M., Kjaer, Susanne K., Sigurdsson, Kristján, Iversen, Ole-Erik, Hernandez-Avila, Mauricio, Perez, Gonzalo, Brown, Darron R., Koutsky, Laura A., Tay, Eng Hseon, García, Patricia, Ault, Kevin A., Garland, Suzanne M., Leodolter, Sepp, Olsson, Sven-Eric, Tang, Grace W. K., Ferris, Daron G., Paavonen, Jorma, Steben, Marc, Bosch, F. Xavier, Dillner, Joakim, Joura, Elmar A., Kurman, Robert J., Majewski, Slawomir, Muñoz, Nubia, Myers, Evan R., Villa, Luisa L., Taddeo, Frank J., Roberts, Christine, Tadesse, Amha, Bryan, Janine, Lupinacci, Lisa C., Giacoletti, Katherine E. D., James, Margaret, Vuocolo, Scott, Hesley, Teresa M., and Barr, Eliav

Published
2009
Full Text
View/download PDF

40. The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV-Naive Women Aged 16-26 Years

Author

Brown, Darron R., Kjaer, Susanne K., Sigurdsson, Kristján, Iversen, Ole-Erik, Hernandez-Avila, Mauricio, Wheeler, Cosette M., Perez, Gonzalo, Koutsky, Laura A., Tay, Eng Hseon, Garcia, Patricía, Ault, Kevin A., Garland, Suzanne M., Leodolter, Sepp, Olsson, Sven-Eric, Tang, Grace W. K., Ferris, Daron G., Paavonen, Jorma, Steben, Marc, Bosch, F. Xavier, Dillner, Joakim, Joura, Elmar A., Kurman, Robert J., Majewski, Slawomir, Muñoz, Nubia, Myers, Evan R., Villa, Luisa L., Taddeo, Frank J., Roberts, Christine, Tadesse, Amha, Bryan, Janine, Lupinacci, Lisa C., Giacoletti, Katherine E. D., Sings, Heather L., James, Margaret, Hesley, Teresa M., and Barr, Eliav

Published
2009
Full Text
View/download PDF

44. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

Author

de Sanjose, Silvia, Quint, Wim GV, Alemany, Laia, Geraets, Daan T, Klaustermeier, Jo Ellen, Lloveras, Belen, Tous, Sara, Felix, Ana, Bravo, Luis Eduardo, Shin, Hai-Rim, Vallejos, Carlos S, de Ruiz, Patricia Alonso, Lima, Marcus Aurelho, Guimera, Nuria, Clavero, Omar, Alejo, Maria, Llombart-Bosch, Antonio, Cheng-Yang, Chou, Tatti, Silvio Alejandro, Kasamatsu, Elena, Iljazovic, Ermina, Odida, Michael, Prado, Rodrigo, Seoud, Muhieddine, Grce, Magdalena, Usubutun, Alp, Jain, Asha, Suarez, Gustavo Adolfo Hernandez, Lombardi, Luis Estuardo, Banjo, Aekunbiola, Menéndez, Clara, Domingo, Efrén Javier, Velasco, Julio, Nessa, Ashrafun, Chichareon, Saibua C Bunnag, Qiao, You Lin, Lerma, Enrique, Garland, Suzanne M, Sasagawa, Toshiyuki, Ferrera, Annabelle, Hammouda, Doudja, Mariani, Luciano, Pelayo, Adela, Steiner, Ivo, Oliva, Esther, Meijer, Chris JLM, Al-Jassar, Waleed Fahad, Cruz, Eugenia, Wright, Thomas C, Puras, Ana, Llave, Cecilia Ladines, Tzardi, Maria, Agorastos, Theodoros, Garcia-Barriola, Victoria, Clavel, Christine, Ordi, Jaume, Andújar, Miguel, Castellsagué, Xavier, Sánchez, Gloria I, Nowakowski, Andrzej Marcin, Bornstein, Jacob, Muñoz, Nubia, and Bosch, F Xavier

Published
2010
Full Text
View/download PDF

47. TIPICO XI: report of the first series and podcast on infectious diseases and vaccines (aTIPICO)

Author

Martinón-Torres, Federico, primary, García-Sastre, Adolfo, additional, Pollard, Andrew J., additional, Martín, Carlos, additional, Osterhaus, Albert, additional, Ladhani, Shamez N, additional, Ramilo, Octavio, additional, Gómez Rial, Jose, additional, Salas, Antonio, additional, Bosch, F Xavier, additional, Martinón-Torres, María, additional, Mina, Michael J., additional, and Cherry, James, additional

Published
2021
Full Text
View/download PDF

49. The male role in cervical cancer

Author

Castellsagué Xavier, Bosch F Xavier, and Muñoz Nubia

Subjects
cervix neoplasms, human papillomavirus, sexually transmitted infections, male role, Public aspects of medicine, RA1-1270
Abstract

Experimental, clinical, and epidemiological evidence strongly suggests that genital Human Papillomaviruses (HPVs) are predominantly sexually transmitted. Epidemiological studies in virginal and HPV-negative women clearly indicate that sexual intercourse is virtually a necessary step for acquiring HPV. As with any other sexually transmitted disease (STD) men are implicated in the epidemiological chain of the infection. Penile HPVs are predominantly acquired through sexual contacts. Sexual contacts with women who are prostitutes play an important role in HPV transmission and in some populations sex workers may become an important reservoir of high-risk HPVs. Acting both as "carriers" and "vectors" of oncogenic HPVs male partners may markedly contribute to the risk of developing cervical cancer in their female partners. Thus, in the absence of screening programs, a woman's risk of cervical cancer may depend less on her own sexual behavior than on that of her husband or other male partners. Although more rarely than women, men may also become the "victims" of their own HPV infections as a fraction of infected men are at an increased risk of developing penile and anal cancers. Male circumcision status has been shown to reduce the risk not only of acquiring and transmitting genital HPVs but also of cervical cancer in their female partners. More research is needed to better understand the natural history and epidemiology of HPV infections in men.

Published
2003

50. Epidemiology of human papillomavirus infections: new options for cervical cancer prevention

Author

Bosch F. Xavier

Subjects
cervical neoplasia/control and prevention, human papillomavirus, control and prevention, Public aspects of medicine, RA1-1270
Abstract

In the last two decades, the cervical cancer puzzle has become a coherent description that includes the identification of human papillomavirus (HPV) as the sexually transmitted etiologic agent and the characterization of the major determinants of HPV acquisition. Triage studies have consistently shown that HPV testing is more sensitive that repeated cytology in identifying underlying high-grade lesions in women with atypical scamous cells of undetermined significance (ASCUS). Studies that reflect primary screening conditions have shown that the sensitivity of HPV tests is higher than standard cytology in detecting high-grade lesions whereas the specificity is similar only in women aged 30-35 and above. HPV vaccines have an intrinsic attraction as a preventive strategy in populations with limited resources. However, vaccines designed to widespread use are still in development and testing phases. Time is ripe for exploring in depth the clinical implications of current achievements and to devise novel strategies for the prevention of cervical cancer.

Published
2003

Catalog

Books, media, physical & digital resources
See catalog results